HT Vet HT VET offers the first non-invasive cancer detection tool for dermal and subcutaneous masses on dogs.

HT Vista is the first non-invasive screening tool that allows vets & nurses to rule out subcutaneous & dermal cancer in their clinic through the power of Heat Diffusion Imaging (HDI) technology.

Some lumps are benign, but palpation isn’t a diagnosis. Use the VISTA iQ as your first step in cancer detection to deter...
28/07/2026

Some lumps are benign, but palpation isn’t a diagnosis. Use the VISTA iQ as your first step in cancer detection to determine whether a lump is harmless or needs further diagnostics, such as an FNA or biopsy.

Learn more at https://eu1.hubs.ly/H0wqV750

25/07/2026

Is malignancy walking out of your clinic undetected and untreated? See how VISTA iQ can improve cancer screening before you perform a biopsy or FNA.

Get the full Clinician’s Brief report at https://eu1.hubs.ly/H0wqV7Z0

Learn more about how VISTA iQ can simplify your cancer screening workflows. Get the playbook for screening dermal and su...
23/07/2026

Learn more about how VISTA iQ can simplify your cancer screening workflows. Get the playbook for screening dermal and subcutaneous masses today at https://eu1.hubs.ly/H0wTlnn0.

🗓️ 1 CE Webinar | July 27 @ 1 PMCommon Misconceptions in General Practice: Unpacking Assumptions About Cancer Screening ...
22/07/2026

🗓️ 1 CE Webinar | July 27 @ 1 PM
Common Misconceptions in General Practice: Unpacking Assumptions About Cancer Screening for Lumps & Bumps

Register at https://eu1.hubs.ly/H0wTlN10

Canine masses are common, but consistent evaluation is not always easy.

Join Dr. Natalie Marks, Dr. Craig Clifford, and Dr. Liron Levy-Hirsch for an interactive webinar on mass screening in general practice. Learn how noninvasive risk assessment can help bridge the gap between “we found a lump” and “we know what to do next.”

This session will cover cytology, client communication, testing barriers, and practical decision-making for earlier cancer detection.

Today, nearly 2/3rd of dermal and subcutaneous masses go untested. Get a playbook for how to rule out cancer before you ...
20/07/2026

Today, nearly 2/3rd of dermal and subcutaneous masses go untested. Get a playbook for how to rule out cancer before you aspirate or biopsy.

Get your copy at https://eu1.hubs.ly/H0wqMQh0

16/07/2026

Cancer screening tools like the VISTA iQ can support a collaborative care effort for patients with lumps and bumps. Lump screenings can be performed in general practice and referred to specialists if needed.

Learn more at https://eu1.hubs.ly/H0wqQdD0

Lipomas are common, and so are misconceptions about them. Download this guide to discover the truth about diagnosing and...
14/07/2026

Lipomas are common, and so are misconceptions about them. Download this guide to discover the truth about diagnosing and managing these prevalent lumps.

https://eu1.hubs.ly/H0wqSMr0

12/07/2026

Bring innovation to your cancer detection protocols. Spectrum of care is more important than ever. Add the VISTA iQ to provide a low-cost, non-invasive first step for screening lumps and bumps.

Learn more at https://eu1.hubs.ly/H0wyVN10

Often, dogs present with multiple lumps. A 40-second scan with the VISTA iQ can determine which masses need an FNA and w...
11/07/2026

Often, dogs present with multiple lumps. A 40-second scan with the VISTA iQ can determine which masses need an FNA and which are benign. These non-invasive scans improve the detection of malignancy and help veterinary teams focus on the masses that need attention.

🗓️ 1 CE Webinar | July 27 @ 1 PMCommon Misconceptions in General Practice: Unpacking Assumptions About Cancer Screening ...
10/07/2026

🗓️ 1 CE Webinar | July 27 @ 1 PM
Common Misconceptions in General Practice: Unpacking Assumptions About Cancer Screening for Lumps & Bumps

Register at https://eu1.hubs.ly/H0wTlxr0

New cancer screening technologies have raised important questions from veterinary teams:

Where do they fit?
Do they replace cytology?
How accurate are they?
How do we explain them to clients?
When should we use them?

Join Dr. Natalie Marks, Dr. Craig Clifford, and Dr. Liron Levy-Hirsch for an interactive webinar on canine mass screening and the evolving role of noninvasive risk assessment in general practice.

Attendees will leave with a clearer understanding of how these tools can support earlier cancer detection, help prioritize FNAs or biopsies, and improve decision-making without overstating the technology.

Address

The NEC
Birmingham
B40 1NT

Alerts

Be the first to know and let us send you an email when HT Vet posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to HT Vet:

Share